Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RNA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
RNA
Atrium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
RNA
Atrium Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
RNA
with
LLY
Uncorrelated: r 0.21 · 155D.
Shared co-movers
2
with RNA
with LLY
MRK
Merck & Co., Inc.
r 0.32
r 0.42
ABBV
AbbVie Inc.
r 0.28
r 0.37
RNA, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
RNA
Atrium Therapeutics, Inc.
Change
8.64
▼
−0.87%
· post 8.64
Mkt cap
$149.2M
Revenue
$3M
Q2 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,419.27
Closed
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 4 '26
RNA
Atrium Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
8.64
▼
−0.87%
post 8.64
Price
1,417.89
▲
+0.60%
post 1,419.27
$149.2M
Mkt cap
$1.3T
Q2 FY26
$3M
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
RNA
8.64
▼
−0.87%
vs
LLY
1,417.89
▲
+0.60%
Closed
Nov 4 '26